Abstract
The transcription factor forkhead box P3 (FOXP3) has been identified as a marker of CD4+CD25+ regulatory T cells and is a key determinant of their immunosuppressive functions. FOXP3 has indeed been shown to limit antitumor immune responses during tumor progression. In addition, by expressing FOXP3, tumor cells may evade effector T-cell responses. © 2013 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Grimmig, T., Kim, M., Germer, C. T., Gasser, M., & Waaga-Gasser, A. M. (2013). The role of FOXP3 in disease progression in colorectal cancer patients. OncoImmunology, 2(6). https://doi.org/10.4161/onci.24521
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free